Gazi \u00dcniversitesi T\u0131p Fak\u00fcltesi Hastanesi G\u00f6z Hastal\u0131klar\u0131 Ana Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Do\u00e7. Dr. Tuba Atalay, AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, sadece \u00e7ocukluk \u00e7a\u011f\u0131nda g\u00f6r\u00fclen g\u00f6z i\u00e7i kanseri “retinoblastom” ve bu hastal\u0131\u011f\u0131n erken d\u00f6nemde te\u015fhis ve tedavisinin \u00f6nemine ili\u015fkin bilgileri payla\u015ft\u0131.<\/p>\n
Hastal\u0131\u011f\u0131n ciddi hayati risk olu\u015fturdu\u011funa dikkati \u00e7eken Atalay, “Retinoblastom, \u00e7ocukluk \u00e7a\u011f\u0131n\u0131n en s\u0131k g\u00f6r\u00fclen g\u00f6z i\u00e7i k\u00f6t\u00fc huylu t\u00fcm\u00f6r\u00fcd\u00fcr. G\u00f6zde beyaz \u0131\u015f\u0131k parlamas\u0131, i\u00e7e veya d\u0131\u015fa do\u011fru \u015fa\u015f\u0131l\u0131k bu t\u00fcm\u00f6r\u00fcn en s\u0131k kar\u015f\u0131la\u015f\u0131lan belirtileri. Bu hastal\u0131k s\u0131kl\u0131kla 1-2 ya\u015f, yani erken \u00e7ocukluk d\u00f6neminde ortaya \u00e7\u0131k\u0131yor, nadiren daha b\u00fcy\u00fck \u00e7ocuklarda da kar\u015f\u0131la\u015f\u0131yoruz.” dedi.<\/p>\n
Atalay, g\u00f6z i\u00e7i kanserinde erken tan\u0131n\u0131n b\u00fcy\u00fck \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 vurgulayarak “Erken tan\u0131 hastal\u0131\u011f\u0131n kaderini belirliyor. Aileler zaten g\u00f6zde parlama gibi belirtiler oldu\u011funda uzmanlara ba\u015fvuruyor ancak asl\u0131nda bu belirtiler hastal\u0131\u011f\u0131n da ilerlemi\u015f oldu\u011funu g\u00f6steriyor. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131n\u0131n program\u0131nda yer alan, \u00f6zellikle ilk 1 ya\u015fa kadar olan d\u00f6nemde yap\u0131lan rutin g\u00f6z muayeneleri hastal\u0131\u011f\u0131n erken tan\u0131s\u0131 i\u00e7in \u00e7ok \u00f6nemli. Bu sayede tedavide y\u00fcz g\u00fcld\u00fcr\u00fcc\u00fc sonu\u00e7lar alabiliyoruz.” diye konu\u015ftu.<\/p>\n
![\"\"](\"https:\/\/www.aa.com.tr\/uploads\/userFiles\/7e80dc7f-a011-4033-a881-3a6b5b580d82\/20230615_2_59121168_90074808.jpg\"\/)
<\/p>\n
“Tedavideki ilk amac\u0131m\u0131z t\u00fcm\u00f6r\u00fcn yay\u0131lmas\u0131n\u0131 engellemek”<\/h3>\n
Do\u00e7. Dr. Atalay, retinoblastom tedavisinde ilk olarak t\u00fcm\u00f6r\u00fcn yay\u0131lmas\u0131n\u0131n \u00f6nlenmesine odaklan\u0131ld\u0131\u011f\u0131n\u0131 belirterek \u015funlar\u0131 kaydetti:<\/p>\n
“K\u00f6t\u00fc huylu t\u00fcm\u00f6r yay\u0131ld\u0131\u011f\u0131nda \u00e7ocuk a\u00e7\u0131s\u0131ndan hayati risk olu\u015fturur. Bu nedenle tedavideki ilk amac\u0131m\u0131z \u00e7ocu\u011fumuzun hayat\u0131n\u0131 kurtarmak. \u0130kinci a\u015famada ise t\u00fcm\u00f6r\u00fcn bulundu\u011fu g\u00f6z\u00fc kurtarmaya odaklan\u0131yoruz. Retinoblastom tedavisinde d\u00fcnyada kullan\u0131lan t\u00fcm g\u00fcncel tedaviler \u00fclkemizde de uygulan\u0131yor. Genel veya b\u00f6lgesel uygulanan kemoterapiler, buna e\u015flik eden \u015fekilde lazer, dondurma tedavisi gibi lokal tedaviler, g\u00f6z i\u00e7ine kemoterapi uygulamas\u0131 gibi tedavileri de uygulamaktay\u0131z.”<\/p>\n
“G\u00f6z muayenelerini genel anesteziyle yapmak zorunday\u0131z”<\/h3>\n
\u0130lerlemi\u015f t\u00fcm\u00f6rlerde ise farkl\u0131, giri\u015fimsel tedaviler yap\u0131lmas\u0131 gerekti\u011fini aktaran Atalay, “Tan\u0131dan itibaren \u00e7ocuklar\u0131m\u0131z\u0131n g\u00f6z muayenesi anestezi alt\u0131nda uyutularak yap\u0131l\u0131yor. \u00d6zellikle hastal\u0131\u011f\u0131n ilk 1 y\u0131l\u0131nda d\u00fczenli olarak neredeyse her ay genel anesteziyle muayeneyi ger\u00e7ekle\u015ftirmek zorunday\u0131z.” bilgisini payla\u015ft\u0131.<\/p>\n
2,5 ya\u015f\u0131ndaki \u00e7ocuk g\u00f6z i\u00e7ine uygulanan kemoterapiyle hayata tutundu<\/h3>\n
\u00d6te yandan AA ekibi, lokal kemoterapi sayesinde hayati riski atlatan 2,5 ya\u015f\u0131ndaki retinoblastom hastas\u0131 bir \u00e7ocu\u011fun ameliyathanedeki g\u00f6z muayenesinin t\u00fcm a\u015famalar\u0131n\u0131 g\u00f6r\u00fcnt\u00fcledi.<\/p>\n
\u00c7ocu\u011fun tan\u0131 ve tedavi s\u00fcrecine y\u00f6nelik bilgileri payla\u015fan Do\u00e7. Dr. Atalay, \u015funlar\u0131 kaydetti:<\/p>\n
“\u00c7ocu\u011fumuz bize ilk geldi\u011finde 12 ayl\u0131kt\u0131. Ailesi g\u00f6z bebe\u011finde beyaz bir \u0131\u015f\u0131k parlamas\u0131 fark ederek bize ba\u015fvurmu\u015ftu. Muayenesinde g\u00f6z i\u00e7inde k\u00f6t\u00fc huylu bir t\u00fcm\u00f6r, yani kanser oldu\u011funu tespit ettik. \u00c7ocu\u011fumuza kas\u0131k yoluyla g\u00f6z damar\u0131na ula\u015farak b\u00f6lgesel kemoterapi uyguland\u0131.<\/p>\n
\u015eu anda \u00e7ocu\u011fumuz 2,5 ya\u015f\u0131nda. En \u00f6nemlisi t\u00fcm\u00f6r\u00fcn v\u00fccuda yay\u0131lmas\u0131 engellendi, hayatta kal\u0131m\u0131 sa\u011fland\u0131. \u015eimdi d\u00fczenli takip ve kontrollerle s\u00fcreci devam ettiriyoruz. Bug\u00fcn de ameliyathanede genel anesteziyle g\u00f6z muayenesini ger\u00e7ekle\u015ftirdik, her \u015fey yolunda. Genel olarak g\u00f6z kanseri tedavisi tamamlanan t\u00fcm \u00e7ocuklarda \u00f6m\u00fcr boyu 6 ayda bir rutin g\u00f6z muayenelerini tekrarlamaktay\u0131z.”<\/p>\n